Tykerb EAP Trials

[Joe]

Hi Joe,
GSK has answered some questions about the EAP program.

Prior to putting a patient on the EAP, the oncologist is asked to evaluate the patient's eligibility for one of our ongoing trials - 104900, a study of Lapatinib in combination with trastuzumab versus lapatinib monotherapy in patients with metastatic breast cancer whose disease has progressed on trastuzumab-containing regimens, 105084 (brain mets) and 103009, the inflammatory breast cancer study. If the patient is eligible for one of them, we ask that they be put on the ongoing study. If they are not eligible for one of these studies, then they of course could come on the EAP as long as they are eligible for that. If it turns out that the patient is eligible for one of the ongoing studies, but does not have reasonable access to an open study site (defined as about a 3 hour drive), they could go on the EAP in that instance, also.

If the site (oncologist) has been attempting to call someone at GSK and not getting a response, please have them contact me so I can put them in touch with the right person.
Thanks so much.
Cathy

[mts]

What is the EAP?

Maria

[lkc Gumby]

Maria,
Expanded Access Program ( for LAPINATIB)

linda

[IRENE FROM TAMPA]

Joe I am currently trying to get into the EAP program at my local onc. office. I was told if there was a ongoing study with Tykerb in the area I might not qualify. The co-ordinator could not reach someone at GSK today to clarify and I am running out of time since it has been 5 weeks without chemo for me.

Cathy said in your message to contact her. Where would we contact her for this question. The closest facility near me is at least 3 hours away so I would like to stay at my doctors office.

Can you help??

Thx much

[Sandy H]

Cathy didn't leave a number for our doctor to call. Can someone provide us with that? Or do they just call GSK and ask for Cathy? Thanks in advance, Sandy

[lindaw]

Joe. Would that number also be for Australia Onc too.

Thanks
lindaw